Whitepaper

Adare Pharmaceuticals, Inc. Acquires Orbis Biosciences

Download

PNG 82 kB

Adare Pharmaceuticals, Inc. Acquires Orbis Biosciences

• Kansas-based pharmaceutical technology company develops customized formulations and intellectual property
• Deal includes platforms that can be dosed in oral, injectable and otic (ear) formulations
• Acquisition expands Adare’s technology platforms and product development capabilities